Use of Biosimilars in Pediatric Inflammatory Bowel Disease: An Updated Position Statement of the Pediatric IBD Porto Group of ESPGHAN-Reference-Cited by-同舟云学术

Use of Biosimilars in Pediatric Inflammatory Bowel Disease: An Updated Position Statement of the Pediatric IBD Porto Group of ESPGHAN

Published:2019-01 Issue:1 Volume:68 Page:144-153
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

de Ridder Lissy,Assa Amit,Bronsky Jiri,Romano Claudio,Russell Richard K.,Afzal Nadeem A.,Hauer Almuthe C.,Knafelz Daniela,Lionetti Paolo,Strisciuglio Caterina,Veres Gábor,Winter Harland,Wolters Victorien M.,Sladek Malgorzata,Vulto Arnold G.,Dias Jorge A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology and Child Health

Reference90 articles.

1. Biosimilars in the therapy of inflammatory bowel diseases;Hlavaty;Eur J Gastroenterol Hepatol,2014

2. Biosimilars in inflammatory bowel disease—accumulating clinical evidence;McConachie;Expert Rev Clin Pharmacol,2017

3. IBD: Indication extrapolation for anti-TNF biosimilars;Vande Casteele;Nat Rev Gastroenterol Hepatol,2015

4. IOM review of FDA-approved biologics labeled or studied for pediatric use;Field;Pediatrics,2013

5. The use of biosimilars in paediatric inflammatory bowel disease;Jongsma;Curr Opin Pediatr,2017

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents;Saudi Journal of Gastroenterology;2024-08-30

3. Comparison of endoscopic healing and durability between infliximab originator and CT-P13 in pediatric patients with inflammatory bowel disease;Frontiers in Immunology;2024-02-22

4. Direct transition from rapid-infusion originator to rapid-infusion biosimilar tumor necrosis factor inhibitor in children with inflammatory bowel disease: A case series;American Journal of Health-System Pharmacy;2023-09-29

5. A violens öngyilkossági kísérletek számának változása a COVID–19-járvány első két évében a Dr. Manninger Jenő Baleseti Központban.;Orvosi Hetilap;2023-07-02